DE69920418D1 - Arzneimittel gegen hepatitis - Google Patents
Arzneimittel gegen hepatitisInfo
- Publication number
- DE69920418D1 DE69920418D1 DE69920418T DE69920418T DE69920418D1 DE 69920418 D1 DE69920418 D1 DE 69920418D1 DE 69920418 T DE69920418 T DE 69920418T DE 69920418 T DE69920418 T DE 69920418T DE 69920418 D1 DE69920418 D1 DE 69920418D1
- Authority
- DE
- Germany
- Prior art keywords
- against hepatitis
- hepatitis
- medicine against
- poly
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7605598 | 1998-03-24 | ||
JP7605598 | 1998-03-24 | ||
PCT/JP1999/001438 WO1999048531A1 (fr) | 1998-03-24 | 1999-03-23 | Nouveaux remedes contre l'hepatite |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69920418D1 true DE69920418D1 (de) | 2004-10-28 |
DE69920418T2 DE69920418T2 (de) | 2005-10-06 |
Family
ID=13594103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69920418T Expired - Lifetime DE69920418T2 (de) | 1998-03-24 | 1999-03-23 | Arzneimittel gegen hepatitis |
Country Status (12)
Country | Link |
---|---|
US (1) | US7205282B1 (de) |
EP (1) | EP1064950B1 (de) |
JP (1) | JP3804452B2 (de) |
KR (1) | KR100520738B1 (de) |
CN (1) | CN1200736C (de) |
AT (1) | ATE276768T1 (de) |
AU (1) | AU2855099A (de) |
CA (1) | CA2325550A1 (de) |
DE (1) | DE69920418T2 (de) |
MY (1) | MY134896A (de) |
RU (1) | RU2226102C2 (de) |
WO (1) | WO1999048531A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999061032A1 (fr) * | 1998-05-25 | 1999-12-02 | Nippon Shinyaku Co., Ltd. | Procede de production d'une preparation composite contenant de l'acide nucleique |
CA2459373A1 (en) * | 2001-09-04 | 2003-03-20 | Nippon Shinyaku Co., Ltd. | Method of evaluating efficacy of nucleic acid therapy |
DE10361502A1 (de) * | 2003-12-23 | 2005-07-28 | Phenion Gmbh & Co. Kg | Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen |
JP4721642B2 (ja) * | 2004-01-20 | 2011-07-13 | サントリーホールディングス株式会社 | 肝障害を伴う肝臓疾患の予防又は改善剤 |
WO2006129594A1 (ja) | 2005-05-30 | 2006-12-07 | Nippon Shinyaku Co., Ltd. | 核酸含有複合体製剤の製造方法 |
EP2119738B1 (de) | 2007-02-05 | 2014-04-16 | Nippon Shinyaku Co., Ltd. | Polyethylenglykolderivat |
CN101686990A (zh) * | 2007-03-19 | 2010-03-31 | 小原道法 | 抗病毒剂 |
KR20110031168A (ko) * | 2008-06-19 | 2011-03-24 | 니뽄 신야쿠 가부시키가이샤 | 약물 담체 |
EA019268B1 (ru) * | 2010-12-01 | 2014-02-28 | Общество С Ограниченной Ответственностью "Анвилаб" | Комбинированное средство, обладающее гепатопротекторным действием |
CN105824410B (zh) * | 2016-02-22 | 2017-09-15 | 维沃移动通信有限公司 | 一种自动滚屏阅读方法及移动终端 |
CN110433173A (zh) * | 2019-07-19 | 2019-11-12 | 成都市海通药业有限公司 | 聚肌胞注射液及用于降低聚肌胞注射液内毒素的方法 |
CN116354836A (zh) * | 2022-03-25 | 2023-06-30 | 深圳市新合生物医疗科技有限公司 | 阳离子脂质化合物及其制备方法和应用、以及mRNA递送系统 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4140761A (en) * | 1977-04-11 | 1979-02-20 | The United States Of America As Represented By The Department Of Health, Education & Welfare | Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen |
US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US5298614A (en) * | 1986-01-06 | 1994-03-29 | Nippon Shinyaku Co. Ltd. | Size limited double stranded poly I poly(cytidylate/4-thiouridylate) |
EP0685234B1 (de) | 1993-02-19 | 2000-05-10 | Nippon Shinyaku Company, Limited | Arzneistoffzusammensetzung, die ein nukleinsäurecopolymer enthält |
TW524693B (en) | 1997-10-16 | 2003-03-21 | Nippon Shinyaku Co Ltd | Cancer cell nuclease activator |
-
1999
- 1999-03-23 EP EP99909297A patent/EP1064950B1/de not_active Expired - Lifetime
- 1999-03-23 RU RU2000126741/15A patent/RU2226102C2/ru not_active IP Right Cessation
- 1999-03-23 KR KR10-2000-7010449A patent/KR100520738B1/ko not_active IP Right Cessation
- 1999-03-23 WO PCT/JP1999/001438 patent/WO1999048531A1/ja active IP Right Grant
- 1999-03-23 MY MYPI99001091A patent/MY134896A/en unknown
- 1999-03-23 JP JP2000537578A patent/JP3804452B2/ja not_active Expired - Fee Related
- 1999-03-23 AT AT99909297T patent/ATE276768T1/de not_active IP Right Cessation
- 1999-03-23 CA CA002325550A patent/CA2325550A1/en not_active Abandoned
- 1999-03-23 DE DE69920418T patent/DE69920418T2/de not_active Expired - Lifetime
- 1999-03-23 CN CNB998043338A patent/CN1200736C/zh not_active Expired - Fee Related
- 1999-03-23 US US09/646,135 patent/US7205282B1/en not_active Expired - Fee Related
- 1999-03-23 AU AU28550/99A patent/AU2855099A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20010042093A (ko) | 2001-05-25 |
CN1294518A (zh) | 2001-05-09 |
AU2855099A (en) | 1999-10-18 |
RU2226102C2 (ru) | 2004-03-27 |
WO1999048531A1 (fr) | 1999-09-30 |
EP1064950B1 (de) | 2004-09-22 |
CA2325550A1 (en) | 1999-09-30 |
MY134896A (en) | 2007-12-31 |
US7205282B1 (en) | 2007-04-17 |
KR100520738B1 (ko) | 2005-10-12 |
DE69920418T2 (de) | 2005-10-06 |
EP1064950A1 (de) | 2001-01-03 |
JP3804452B2 (ja) | 2006-08-02 |
ATE276768T1 (de) | 2004-10-15 |
EP1064950A4 (de) | 2002-11-27 |
CN1200736C (zh) | 2005-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4497905T1 (de) | Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms | |
AU7476894A (en) | Method of treating atherosclerosis or restenosis using microtubule stabilizing agent | |
WO2002056912A3 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
BG103786A (bg) | Състав и метод за профилактика и лечение на нiv и други инфекциозни заболявания при човека | |
DE69920418D1 (de) | Arzneimittel gegen hepatitis | |
PL372925A1 (en) | Prevention and treatment of restenosis by local administration of drug | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
HUP0104709A2 (hu) | Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására | |
ATE207743T1 (de) | Pharmazeutische präparate zur gezielten behandlung von morbus crohn und colitis ulcerosa | |
RS114004A (en) | Modified 2' and 3'-nucleoside produgs for treating flaviridae infections | |
PT1040830E (pt) | Medicamento para doencas neurodegenerativas | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
ATE309798T1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
EA200200812A1 (ru) | Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение | |
ATE141790T1 (de) | Medikament zur hemmung der stickoxid-bildung | |
DE69527506D1 (de) | Delta 12,16-isotaxol analoge mit antineoplastischer wirkung und pharmazeutische zusammensetzungen sie enthaltend | |
DE60016460D1 (de) | Verwendungen und zusammenstellungen von nitratestern als sedativa | |
BG105302A (en) | Means for improving cognition | |
NZ513650A (en) | Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo | |
SI0770384T1 (en) | Solid, anhydrous, pharmaceutical compositions for vaginal use | |
SE9201930D0 (sv) | Gastric antibacterial treatment | |
DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
ATE106732T1 (de) | Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung. | |
EA199900963A1 (ru) | Лекарственные формы сертралина в виде раствора, заключенного в желатиновые капсулы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |